Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Expression of vimentin and survivin in clear cell renal cell carcinoma and correlation with p53.

Shi ZG, Li SQ, Li ZJ, Zhu XJ, Xu P, Liu G.

Clin Transl Oncol. 2015 Jan;17(1):65-73. doi: 10.1007/s12094-014-1199-1.

PMID:
25028191
3.

Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma.

Baytekin F, Tuna B, Mungan U, Aslan G, Yorukoglu K.

Urol Oncol. 2011 Sep-Oct;29(5):502-7. doi: 10.1016/j.urolonc.2009.09.001.

PMID:
19945306
4.

High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.

Wu XR, Sha JJ, Liu DM, Chen YH, Yang GL, Zhang J, Chen YY, Bo JJ, Huang YR.

Eur J Surg Oncol. 2013 Jan;39(1):100-6. doi: 10.1016/j.ejso.2012.10.004.

PMID:
23102595
5.

hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.

Dong X, Kong C, Zhang Z, Liu X, Zhan B, Chen Z, Shi D.

Urol Oncol. 2014 Aug;32(6):885-92. doi: 10.1016/j.urolonc.2014.02.021.

PMID:
24878177
6.

Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma.

Zhuang Q, Qian X, Cao Y, Fan M, Xu X, He X.

J Int Med Res. 2014 Apr;42(2):282-91. doi: 10.1177/0300060513505524.

PMID:
24514433
7.

Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance.

Lei Y, Geng Z, Guo-Jun W, He W, Jian-Lin Y.

Mol Cell Biochem. 2010 Nov;344(1-2):23-31. doi: 10.1007/s11010-010-0525-3.

PMID:
20563741
8.

LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer.

Yang F, Zhou X, Du S, Zhao Y, Ren W, Deng Q, Wang F, Yuan J.

PLoS One. 2014 Jun 23;9(6):e100557. doi: 10.1371/journal.pone.0100557.

9.

High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.

Zhang HM, Yang FQ, Yan Y, Che JP, Zheng JH.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):5801-9.

10.

Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.

Ma X, Fan Y, Gao Y, Zhang Y, Huang Q, Ai Q, Ni D, Chen W, Zhang P, Song E, Wang B, Shi T, Zheng T, Zhang X.

Urol Oncol. 2014 Jan;32(1):46.e9-17. doi: 10.1016/j.urolonc.2013.06.011.

PMID:
24094887
11.

Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma.

Yin B, Zeng Y, Wang X, Liu G, Zhang M, Song Y.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):4112-9.

12.

Decreased expression of NPRL2 in renal cancer cells is associated with unfavourable pathological, proliferation and apoptotic features.

Tang Y, Jiang L, Tang W.

Pathol Oncol Res. 2014 Oct;20(4):829-37. doi: 10.1007/s12253-014-9761-2.

PMID:
24789683
13.

CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities.

Xie J, Yuan Y, Liu Z, Xiao Y, Zhang X, Qin C, Sheng Z, Xu T, Wang X.

Clin Transl Oncol. 2014 Apr;16(4):402-9. doi: 10.1007/s12094-013-1092-3.

PMID:
23907292
14.

MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.

Heinzelmann J, Unrein A, Wickmann U, Baumgart S, Stapf M, Szendroi A, Grimm MO, Gajda MR, Wunderlich H, Junker K.

Ann Surg Oncol. 2014 Mar;21(3):1046-54. doi: 10.1245/s10434-013-3361-3.

PMID:
24242678
15.

NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.

Meteoglu I, Erdogdu IH, Meydan N, Erkus M, Barutca S.

J Exp Clin Cancer Res. 2008 Oct 19;27:53. doi: 10.1186/1756-9966-27-53.

16.

Expression of CIDE proteins in clear cell renal cell carcinoma and their prognostic significance.

Yu M, Wang H, Zhao J, Yuan Y, Wang C, Li J, Zhang L, Zhang L, Li Q, Ye J.

Mol Cell Biochem. 2013 Jun;378(1-2):145-51. doi: 10.1007/s11010-013-1605-y.

17.
18.

[The expression and clinical significance of Annexin II in clear-cell renal cell carcinoma].

Yang J, Cheng TT, Wang LN, Chen W, Li X.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Jan;28(1):59-62. Chinese.

PMID:
22230505
19.

The expression and role of MEKK3 in renal clear cell carcinoma.

Lu H, Cao X, Chen Q, Chen L, Chen L, Gan M.

Anat Rec (Hoboken). 2015 Apr;298(4):727-34. doi: 10.1002/ar.23093.

20.

PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.

Godlewski J, Krazinski BE, Kowalczyk AE, Kiewisz J, Kiezun J, Kwiatkowski P, Sliwinska-Jewsiewicka A, Maslowski Z, Kmiec Z.

Anticancer Res. 2016 Feb;36(2):617-24.

PMID:
26851016

Supplemental Content

Support Center